glp 1 autoimmune disease Frontiers GLP1 microdosing for autoimmune conditions?
Description
It is not known if these medicines will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people
Dipeptidyl-peptidase IV from bench to bedside: An update on structural properties, functions, and clinical aspects of the enzyme DPP IV
The decision to use these treatments should involve a comprehensive discussion of individual risk factors, family history, and the balance between metabolic benefits and potential concerns
Dizziness or Fainting: This could indicate low blood pressure or significant dehydration
